In the absence of a submission from the holder of the marketing authorisation: tadalafil (Cialis) is not recommended for use within NHS Scotland.
Indication under review: Treatment of the signs and symptoms of benign prostatic hyperplasia in adult males.
The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication. As a result we cannot recommend its use within NHSScotland.
|Drug Name:||tadalafil (Cialis)|
|SMC Drug ID:||849/12|
|Manufacturer:||Eli Lilly and Company Ltd|
|Indication:||Treatment of the signs and symptoms of benign prostatic hyperplasia in adult males.|
|Sub Category:||7.4 Drugs for genito-urinary disorders|
|Submission Type:||Non submission|
|Date Advice Published:||14 January 2013|